Thoughts on Healthcare Markets & Technology
Thoughts on Healthcare Markets & Technology Podcast
What does 17 pharma MFN deals are underneath the press releases: the real primary source stack, the GLP1 numbers, TrumpRX plumbing, and where the new adjudication layer gets monetized
0:00
-15:37

Paid episode

The full episode is only available to paid subscribers of Thoughts on Healthcare Markets & Technology

What does 17 pharma MFN deals are underneath the press releases: the real primary source stack, the GLP1 numbers, TrumpRX plumbing, and where the new adjudication layer gets monetized

The viral "17 pharma companies" headline is real, but the actual deal structure is nothing like what was reported.

The Most Favored Nation drug pricing push generated enormous coverage when the White House announced 17 pharmaceutical companies had agreed to terms. This episode reconstructs the full picture from the primary source stack — the July 2025 demand letters, the rolling deal announcements, and the executive order text itself — because the secondary coverage…

User's avatar

Continue reading this post for free, courtesy of Thoughts on Healthcare.